ReproCELL Management
Management criteria checks 2/4
ReproCELL's CEO is Shuji Yokoyama, appointed in Nov 2005, has a tenure of 19.08 years. directly owns 1.09% of the company’s shares, worth €626.74K. The average tenure of the management team and the board of directors is 4.9 years and 8 years respectively.
Key information
Shuji Yokoyama
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 19.1yrs |
| CEO ownership | 1.1% |
| Management average tenure | 4.9yrs |
| Board average tenure | 8yrs |
Recent management updates
Recent updates
CEO
Shuji Yokoyama (56 yo)
19.1yrs
Tenure
Dr. Shuji Yokoyama, Ph D serves as the Chief Executive Officer of ReproCELL Incorporated since 2020 and has been its President since November 2005. Dr. Yokoyama joined ReproCELL Inc. in 2004 as General Man...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 19.1yrs | no data | 1.09% € 626.7k | |
| COO & Director | 4.1yrs | no data | 0.20% € 112.5k | |
| CEO of REPROCELL USA Ltd & CEO of Bioserve Biotechnologies India | 4.9yrs | no data | no data | |
| Chief Executive officer of REPROCELL Europe | 4.9yrs | no data | no data |
4.9yrs
Average Tenure
Experienced Management: 6RC's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 19.1yrs | no data | 1.09% € 626.7k | |
| COO & Director | 8.5yrs | no data | 0.20% € 112.5k | |
| Independent Outside Director | 16.5yrs | no data | 0.053% € 30.6k | |
| Outside Audit & Supervisory Board Member | 2.5yrs | no data | no data | |
| Outside Audit & Supervisory Board Member | 7.5yrs | no data | no data | |
| Outside Audit & Supervisory Board Member | 4.3yrs | no data | no data |
8.0yrs
Average Tenure
58yo
Average Age
Experienced Board: 6RC's board of directors are considered experienced (8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 02:42 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ReproCELL Incorporated is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Akinori Ueda | Goldman Sachs |